Business YishengBio received approval from Philippines for Phase 2/3 Clinical Trials of PIKA Recombinant COVID-19 vaccineBy Team OrangeSeptember 14, 20220 YishengBio Co., Ltd., (“YishengBio”), a biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of new generations of vaccines…
